microRNA biomarkers in cystic diseases
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
microRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by targeting the 3’-untranslated region of multiple target genes. Pathogenesis results from defects in several gene sets; therefore, disease progression could be prevented using miRNAs targeting multiple genes. Moreover, recent studies suggest that miRNAs reflect the stage of the specific disease, such as carcinogenesis. Cystic diseases, including polycystic kidney disease, polycystic liver disease, pancreatic cystic disease, and ovarian cystic disease, have common processes of cyst formation in the specific organ. Specifically, epithelial cells initiate abnormal cell proliferation and apoptosis as a result of alterations to key genes. Cysts are caused by fluid accumulation in the lumen. However, the molecular mechanisms underlying cyst formation and progression remain unclear. This review aims to introduce the key miRNAs related to cyst formation, and we suggest that miRNAs could be useful biomarkers and potential therapeutic targets in several cystic diseases.
Abstract
microRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by targeting the 3’-untranslated region of multiple target genes. Pathogenesis results from defects in several gene sets; therefore, disease progression could be prevented using miRNAs targeting multiple genes. Moreover, recent studies suggest that miRNAs reflect the stage of the specific disease, such as carcinogenesis. Cystic diseases, including polycystic kidney disease, polycystic liver disease, pancreatic cystic disease, and ovarian cystic disease, have common processes of cyst formation in the specific organ. Specifically, epithelial cells initiate abnormal cell proliferation and apoptosis as a result of alterations to key genes. Cysts are caused by fluid accumulation in the lumen. However, the molecular mechanisms underlying cyst formation and progression remain unclear. This review aims to introduce the key miRNAs related to cyst formation, and we suggest that miRNAs could be useful biomarkers and potential therapeutic targets in several cystic diseases.
참고문헌 (86)
- Lee, R. C., "The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14", Cell, 75, pp.843~854 (1993)
- Selbach, M., "Widespread changes in protein synthesis induced by microRNAs", Nature, 455, pp.58~63 (2008)
- Lewis, B. P., "Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets", Cell, 120, pp.15~20 (2005)
- Lindow, M., "Principles and limitations of computational microRNA gene and target finding", DNA Cell Biol, 26, pp.339~351 (2007)
- Hu, Z., "Insight into microRNA regulation by analyzing the characteristics of their targets in humans", BMC Genomics, 10, pp.594~ (2009)
- Bartel, D. P., "MicroRNAs : genomics, biogenesis, mechanism, and function", Cell, 116, pp.281~297 (2004)
- Lopez-Serra, P., "DNA methylation- associated silencing of tumor-suppressor microRNAs in cancer", Oncogene, 31, pp.1609~1622 (2012)
- Ibraghimov-Beskrovnaya, O, "Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies", Cell. Mol. Life Sci, 65, pp.605~619 (2008)
- Janssen, M. J., "Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease", Gastroenterology, 141, pp.2056~2063 (2011)
- Fedeles, S. V., "A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation", Nat. Genet, 43, pp.639~647 (2011)
- Lee, S. H., "Quantitative trait locus analysis of ovarian cysts derived from rete ovarii in MRL", MpJ mice, 2010, pp.21, 162~171
- Abdul-Majeed, S., "Polycystic diseases in visceral organs", Obstet. Gynecol. Int, 2011, pp.609370~ (2011)
- Wallace, D. P., "Cyclic AMP-mediated cyst expansion", Biochim. Biophys. Acta, 1812, pp.1291~1300 (2011)
- 고제영, "Mouse models of polycystic kidney disease induced by defects of ciliary proteins", BMB Reports, 46(2), pp.73~79 (2013), 생화학분자생물학회
- Boehlke, C., "Primary cilia regulate mTORC1 activity and cell size through Lkb1", Nat. Cell Biol, 12, pp.1115~1122 (2010)
- Kim, S., "Nde1-mediated inhibition of ciliogenesis affects cell cycle re-entry", Nat. Cell Biol, 13, pp.351~360 (2011)
- Lancaster, M. A., "Subcellular spatial regulation of canonical Wnt signalling at the primary cilium", Nat. Cell Biol, 13, pp.700~707 (2011)
- Belibi, F., "mTORC1", 2 and rapamycin in female Han: SPRD rats with polycystic kidney disease, 2011, pp.300, F236~F244
- Yamaguchi, T., "Calcium restriction allows cAMP activation of the B-Raf", ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype, 2004, pp.279, 40419~40430
- Slack, F. J., "MicroRNA in cancer prognosis", N. Engl. J. Med, 359, pp.2720~2722 (2008)
- Kim, V. N., "Biogenesis of small RNAs in animals", Nat. Rev. Mol. Cell Biol, 10, pp.126~139 (2009)
- Hu, H. Y., "Sequence features associated with microRNA strand selection in humans and flies", BMC Genomics, 10, pp.413~ (2009)
- Yang, J. S., "Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants", Mol. Cell, 43, pp.892~903 (2011)
- Kim, V. N., "MicroRNA biogenesis: coordinated cropping and dicing", Nat. Rev. Mol. Cell Biol, 6, pp.376~385 (2005)
- Grimson, A., "MicroRNA targeting specificity in mammals: determinants beyond seed pairing", Mol. Cell, 27, pp.91~105 (2007)
- Baskerville, S., "Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes", RNA, 11, pp.241~247 (2005)
- Landgraf, P., "A mammalian microRNA expression atlas based on small RNA library sequencing", Cell, 129, pp.1401~1414 (2007)
- Liu, C. G., "An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues", Proc. Natl. Acad. Sci. U.S.A, 101, pp.9740~9744 (2004)
- Sun, Y., "Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs", Nucleic Acids Res, 32, pp.e188~ (2004)
- Chen, X. M., "MicroRNA signatures in liver diseases", World J. Gastroenterol, 15, pp.1665~1672 (2009)
- Bhatt, K., "microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles", Am. J. Physiol. Renal Physiol, 300, pp.F602~F610 (2011)
- Etheridge, A., "Extracellular microRNA: a new source of biomarkers", Mutat. Res, 717, pp.85~90 (2011)
- Wittmann, J., "Serum microRNAs as powerful cancer biomarkers", Biochim. Biophys. Acta, 1806, pp.200~207 (2010)
- Gilad, S., "Serum microRNAs are promising novel biomarkers", PLoS One, 3, pp.e3148~ (2008)
- Liang, M., "MicroRNA: a new frontier in kidney and blood pressure research", Am. J. Physiol. Renal Physiol, 297, pp.F553~F558 (2009)
- Nahm, A. M., "Renal cystic disease (ADPKD and ARPKD)", Nephrol. Dial. Transplant, 17, pp.311~314 (2002)
- Nagao, S., "Animal models for human polycystic kidney disease", Exp. Anim, 61, pp.477~488 (2012)
- Lee, S. O., "MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease", J. Clin. Invest, 118, pp.3714~3724 (2008)
- Dell, K. M. R., "Polycystic kidney disease, autosomal recessive; in GeneReviews" (1993)
- Kaimori, J. Y, "ARPKD and ADPKD: first cousins or more distant relatives?", J. Am. Soc. Nephrol, 19, pp.416~418 (2008)
- Nicolau, C., "Sonographic pattern of recessive polycystic kidney disease in young adults. Differences from the dominant form", Nephrol. Dial. Transplant, 15, pp.1373~1378 (2000)
- Brasier, J. L., "Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis", J. Clin. Invest, 99, pp.194~199 (1997)
- Ong, A. C., "Polycystin-1 expression in PKD1, early- onset PKD1, and TSC2", PKD1 cystic tissue, 1999, pp.56, 1324~1333
- Takakura, A., "Renal injury is a third hit promoting rapid development of adult polycystic kidney disease", Hum. Mol. Genet, 18, pp.2523~2531 (2009)
- Wang, E., "Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1", J. Pathol, 222, pp.238~248 (2010)
- Pastorelli, L. M., "Genetic analyses reveal a requirement for Dicer1 in the mouse urogenital tract", Mamm. Genome, 20, pp.140~151 (2009)
- Patel, V., "MicroRNAs regulate renal tubule maturation through modulation of Pkd1", J. Am. Soc. Nephrol, 23, pp.1941~1948 (2012)
- 박은영, "Polycystic kidney disease and therapeutic approaches", BMB Reports, 44(6), pp.359~368 (2011), 생화학분자생물학회
- Dweep, H., "Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD", Mhm rat model, 2013, pp.8, e53780~
- Pandey, P., "Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease", BMC Genomics, 9, pp.624~ (2008)
- Tan, Y. C., "Autosomal dominant polycystic kidney disease: genetics, mutations and microRNAs", Biochim. Biophys. Acta, 1812, pp.1202~1212 (2011)
- Sun, H., "MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation", Mol. Biol. Rep, 37, pp.2951~2958 (2010)
- Tran, U., "The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity", Development, 137, pp.1107~1116 (2010)
- Patel, V., "miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease", Proc. Natl. Acad. Sci. U. S. A, 110, pp.10765~10770 (2013)
- Pandey, P., "Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease", BMC Syst. Biol, 5, pp.56~ (2011)
- Attanasio, M., "Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis", Nat. Genet, 39, pp.1018~1024 (2007)
- Gretz, N., "Rat models of autosomal dominant polycystic kidney disease", Nephrol. Dial. Transplant, 11(Suppl 6), pp.46~51 (1996)
- Dweep, H., "miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes", J. Biomed. Inform, 44, pp.839~847 (2011)
- Nicolau, C., "Autosomal dominant polycystic kidney disease types 1 and 2: assessment of US sensitivity for diagnosis", Radiology, 213, pp.273~276 (1999)
- Bae, K. T., "Magnetic resonance imaging evaluation of hepatic cysts in early autosomal- dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort", Clin. J. Am. Soc. Nephrol, 1, pp.64~69 (2006)
- Waanders, E., "Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease", Hum. Mutat, 27, pp.830~ (2006)
- Waanders, E., "Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63", Clin. Genet, 78, pp.47~56 (2010)
- Banales, J. M., "Somatic second-hit mutations leads to polycystic liver diseases", World J. Gastroenterol, 19, pp.141~143 (2013)
- Fabris, L., "Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases", Hepatology, 43, pp.1001~1012 (2006)
- Alvaro, D., "Regulation and deregulation of cholangiocyte proliferation", J. Hepatol, 33, pp.333~340 (2000)
- Qian, Q., "Sirolimus reduces polycystic liver volume in ADPKD patients", J. Am. Soc. Nephrol, 19, pp.631~638 (2008)
- LeSage, G., "Regulation of cholangiocyte proliferation", Liver, 21, pp.73~80 (2001)
- Arnould, T., "The polycystic kidney disease 1 gene product mediates protein kinase C alpha- dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1", J. Biol. Chem, 273, pp.6013~6018 (1998)
- Fernandez-del Castillo, C., "Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients", Arch. Surg, 138, pp.427~423 (2003)
- Park, W. G., "Screening for pancreatic cancer: what can cyst fluid analysis tell us?", F1000 Med. Rep, 3, pp.3~ (2011)
- Ryu, J. K., "Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma", Pancreatology, 11, pp.343~350 (2011)
- Farrell, J. J., "Endoscopically acquired pancreatic cyst fluid MicroRNA 21 and 221 are associated with invasive cancer", Am. J. Gastroenterol (2013)
- Matthaei, H., "miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts", Clin. Cancer Res, 18, pp.4713~4724 (2012)
- Cano, D. A., "Orpk mouse model of polycystic kidney disease reveals essential role of primary cilia in pancreatic tissue organization", Development, 131, pp.3457~3467 (2004)
- Cano, D. A., "Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis", Gastroenterology, 131, pp.1856~1869 (2006)
- Pierreux, C. E., "The transcription factor hepatocyte nuclear factor-6 controls the development of pancreatic ducts in the mouse", Gastroenterology, 130, pp.532~541 (2006)
- Simion, A., "MiR-495 and miR-218 regulate the expression of the Onecut transcription factors HNF-6 and OC-2", Biochem. Biophys. Res. Commun, 391, pp.293~298 (2010)
- Onur, M. R., "Cystic abdominal masses in children: a pictorial essay", Clin. Imaging, 37, pp.18~27 (2013)
- Lee, H. J., ""Daughter cyst" sign: a sonographic finding of ovarian cyst in neonates, infants, and young children", AJR. Am. J. Roentgenol, 174, pp.1013~1015 (2000)
- Legro, R. S., "Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome", N. Engl. J. Med, 356, pp.551~566 (2007)
- Sirotkin, A. V., "Identification of microRNAs controlling human ovarian cell proliferation and apoptosis", J. Cell. Physiol, 223, pp.49~56 (2010)
- Sirotkin, A. V., "Identification of microRNAs controlling human ovarian cell steroidogenesis via a genome- scale screen", J. Cell. Physiol, 219, pp.415~420 (2009)
- Toloubeydokhti, T., "Potential regulatory functions of microRNAs in the ovary", Semin. Reprod. Med, 26, pp.469~478 (2008)
- Hossain, M. M., "Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model", J. Ovarian Res, 6, pp.36~ (2013)
- Sang, Q., "Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo", J. Clin. Endocrinol. Metab, 98, pp.3068~3079 (2013)
- He, A., "Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes", Mol. Endocrinol, 21, pp.2785~2794 (2007)
